Taubman Emerging Scholars Symposium held April 27
Six talented young leaders of the next generation of medical researchers will speak April 27 at the 2nd Annual Emerging Scholars Symposium of the A. Alfred Taubman Medical Research Institute. The symposium will take place April 27 from 10 a.m. to noon at the Kahn Auditorium of the A. Alfred Taubman Biomedical Science Research Building.
These groundbreaking clinician-scientists on the faculty of the University of Michigan Medical School are making remarkable strides toward treatments for life-altering conditions like prostate cancer, wounds that won’t heal, inflammatory skin conditions, deteriorating joints, vision loss and neurological diseases.
The Taubman Institute’s Emerging Scholars Program is aimed at launching the laboratories of U-M’s best and brightest young doctors. The program provides three-year grants of $50,000 per year to help fund medical breakthroughs.
In just a few short years, Taubman Emerging Scholars have initiated nine human clinical trials of new treatments in fields ranging from cancer to inflammatory diseases. With 16 Emerging Scholars now supported – and two dozen more worthy candidates vetted and ready for funding – it’s a program that aims for, and achieves, fast results for patients who can’t wait.
Physicians attending the symposium may be eligible for 2 CME credits per the following criteria:
This symposium will summarize recently-published peer-reviewed research by the Emerging Scholars of the A. Alfred Taubman Medical Research Institute. New information regarding the treatment of various conditions will be presented by the clinician-scientists who authored the research.
At the conclusion of the seminar, participants will be able to implement:
• Better approaches in the treatment of patients with joint damage
• New approaches in the use of diagnostic imaging for patients with neurodegenerative diseases
• Approaches to the management of impaired wound healing in patients with diabetes
• The latest knowledge regarding inflammatory skin diseases
• New approaches to muscle regeneration in patients’ ophthalmology
• The latest knowledge regarding the genomics of prostate cancer
Who should attend:
All are welcome to attend the symposium; no registration is required.
The symposium is open to University of Michigan clinicians and research scientists, as well as other primary care practitioners and public health scholars interested in the most recent discovery regarding these prevalent diseases.
The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Michigan Medical School designates this live activity for a maximum of 2 AMA PRA Category 1 Credit(s).™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Coffee and pastries are served at 9:30 a.m.